CPT 00916: Anesthesia for Bleeding Control After Transurethral Tissue Removal
Commercial payers pay $73 on average nationally for this procedure.
CPT code 00916 describes anesthesia services provided for a patient who requires bleeding control after removal of tissue accessed through the urethra; this represents intraoperative anesthesia for hemostasis management during transurethral procedures, typically delivered in an operating room or ambulatory surgical center under general, regional, or monitored anesthesia care.
For related coverage guidance, see recent payer policy updates: Intravenous Anesthetics for the Treatment of Chronic Pain and Psychiatric or Substance Use Disorders, Intravenous Anesthetics for the Treatment of Chronic Pain and Psychiatric or Substance Use Disorders, Intravenous Anesthetics for the Treatment of Chronic Pain and Psychiatric or Substance Use Disorders.
Customize your policy alerts
Sign up for cpt 00916 policy alerts
Get alerted when payer policies referencing 00916 are released or updated.
Monitor payer policy activity
National Reimbursement Benchmarks
National commercial reimbursement for CPT 00916 centers around BUCA’s average commercial rate of $72.9, which provides a useful mid-market reference. Among named payers, Cigna posts the highest mean at $96.5 while Aetna and UnitedHealth Group sit lower at $62.9 and $67.4 respectively; Blue Cross Blue Shield averages $70.2. Payer medians are generally near their means for Blue Cross Blue Shield and UnitedHealth Group, indicating moderate symmetry in their distributions.
Dispersion measured as P75 minus P25 highlights variation: Cigna has the widest interquartile spread at $58.0 ($125.0 minus $68.4), signaling greater variability in commercial contract rates. Blue Cross Blue Shield’s spread is $36.5 and BUCA’s spread is $36.1, both tighter than Cigna. Aetna’s spread is $41.9 and UnitedHealth Group’s spread is $28.9, making UnitedHealth Group the tightest among these payers.